HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

5-Heptenoic acid, 7-(4-butyloctahydro-2,5-dioxo-1H-inden-1-yl)-

HCID 6438367
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
74158-09-1
Standard SMILES
CCCCC1C(=O)CCC2C(C/C=C/CCCC(=O)O)C(=O)CC12
InChIKey
CGCZPIJMGKLVTQ-GQCTYLIASA-N
Molecular formula
C20H30O4
Average molar mass
334.4 g/mol
Monoisotopic mass
334.21440943

Overview

Bicyclo Prostaglandin E2 is a prostanoid.

Names & identifiers

Preferred name
5-Heptenoic acid, 7-(4-butyloctahydro-2,5-dioxo-1H-inden-1-yl)-
IUPAC
(E)-7-(4-butyl-2,5-dioxo-3,3a,4,6,7,7a-hexahydro-1H-inden-1-yl)hept-5-enoic acid
English name
11-deoxy-15-keto-13,14-dihydro-11 beta,16-cycloprostaglandin E2
Molecular formula
C20H30O4
Molecular weight
334.45

Names & synonyms

5-Heptenoic acid, 7-(4-butyloctahydro-2,5-dioxo-1H-inden-1-yl)-BICYCLO PROSTAGLANDIN E274158-09-1(E)-7-(4-butyl-2,5-dioxo-3,3a,4,6,7,7a-hexahydro-1H-inden-1-yl)hept-5-enoic acidBicyclo-PGEMPgem-IIDKDBCYPGE2PGE2-M11-Deoxy-15-keto-13,14-dihydro-11beta,16-cyclo-PGE2SCHEMBL29889717CHEBI:22852911-deoxy-13,14-dihydro-15-keto-11 beta,16 xi-cyclo-PGE2
Show more names
11-deoxy-15-keto-13,14-dihydro-11 beta,16-cycloprostaglandin E2
11-Deoxy-13,14-dihydro-15-keto-11beta,16xi-cyclo-PGE211-Deoxy-15-keto-13,14-dihydro-11beta,16-cycloprostaglandin E2(E)-7-(4-butyl-2,5-dioxooctahydro-1H-inden-1-yl)hept-5-enoic acid

Database identifiers

CAS
74158-09-1
PubChem CID
6438367
ChEBI
CHEBI:228529

Properties

Computed structural properties

XLogP
3.1
Topological polar surface area
71.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
4
Rotatable bonds
9
Heavy atoms
24
Formal charge
0
Complexity
494

Physicochemical properties

solubility
25 mg/ml; · DMF: >25 mg/ml; DMSO: >25 mg/ml; Ethanol: >30 mg/ml; PBS pH 7.2: >1.4 mg/ml
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
312 · H312-H302
Precautionary statements
280 · P280-P302+P352-P312-P322-P363-P501-P264-P270-P301+P312-P330-P501

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P280, P301+P317, P302+P352, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H312-H302
Precautionary statements
P280-P302+P352-P312-P322-P363-P501-P264-P270-P301+P312-P330-P501

Chemistry & industry

Applications · 1 item

UsesBicyclo prostaglandin E2 (bicyclo PGE2) is a stable breakdown product of PGE2 and 13,14-dihydro-15-keto PGE2 . Bicyclo PGE2 is a stable, base-catalyzed transformation product of 13,14-dihydro-15-keto PGE2. 13,14-dihydro-15-keto PGE2 itself is a metabolite of PGE2 found in human plasma at a median level of 20-25 pg/ml. Due to the inherent instability of 13,14-dihydro-15-keto PGE2, it is advisable to quantify it as bicyclo PGE2 to estimate PGE2 biosynthesis or metabolism in vivo.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
EC Number
633-350-3